Company intelligence / Profile preview
Jinghua Pharmaceutical
- Ownership
- Private
- Employees
- ~1490
- Development stage
- Other
Overview
Jinghua Pharmaceutical is a leading Chinese pharmaceutical company with over six decades of experience in the production of APIs, intermediates, finished drugs, and traditional Chinese medicines. The company has several products approved in China and internationally—including US FDA approvals—and maintains global partnerships. It is active in both generic/specialty pharmaceuticals and biomedicine. Notably, it has entered into collaborations to develop monoclonal antibodies targeting oncology indications.
- Therapeutic areas
- OncologyNeurologyInfectious Diseases
- Modalities
- Small moleculeHerbal medicineMonoclonal antibody
- Industry
- Biotech
Drug pipeline
14 assets13 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Jinghua Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jinghua Pharmaceutical.